The stock of Insulet Corporation (NASDAQ:PODD) increased by $8.27 on Tuesday to finish at $189.48, up 4.56 percent. The last five days have seen an average of 1,558,460 shares of common stock traded. 13 times new highs were reached in the current year, with a fall of -$104.91. The average number of shares traded over the last 20 days was 1,375,110, while the average volume over the last 50 days totaled 850,540.
PODD stock dropped -31.53% since last month. On 08/29/23, the company’s shares reached a one-month low of $178.55. The stock touched a high of $335.91 on 05/05/23, after rallying from a low of $179.37 in 52 weeks. The price of PODD stock has declined by -35.64% or -$104.91 this year, reaching a new high 13 times. Still, the stock price is down -43.59% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
PODD stock investors should be aware that Insulet Corporation (PODD) stock had its last reported insider trading activity 2 days ago on Aug 28. On Aug 28, President and CEO Hollingshead James acquired 5,550 shares at $181.41 each. This transaction resulted in the insider spending $1,006,826. On Jul 03, McMillan Wayde D. sold 1,388 shares at a price of US$282.94. After the transaction, the insider now owns 21,477 shares. SVP, Chief HR Officer Manea Dan had earlier sold 175 shares on Jun 20 for $290.00 a share. The transaction was completed for $50,750.
Valuation Metrics
Insulet Corporation (PODD) has a trailing price-to-earnings (P/E) ratio of 212.66. Beta for the stock is 0.84. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 9.27, the price-to-book (PB) ratio of 23.86.
Financial Health
For the recent quarter, Insulet Corporation’s quick ratio was 2.40, while its current ratio was 3.30, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the recent quarter is 2.47, and the total debt to equity ratio is 2.52. As far as profitability goes, gross margin for the trailing twelve months is 62.20% percent. Insulet Corporation’s EBITDA margin for the recent year was 7.72%, whereas its operating margin stood at 5.80% for the same period. Based on annual data, it had gross profit of $805.6 million and revenue of $1.31 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. PODD’s return on assets (ROA) during the last 12 months has been 2.80%. There was a 1.70% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 12.80%.
Earnings Surprise
A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $396.5 million, while revenues rose by 24.49% to $358.1 million. EBITDA was $49.2 million for the quarter. At the end of Insulet Corporation’s most recent quarter, its liabilities totaled 1.83 billion, while its total debt was $1.4 billion. Equity owned by shareholders amounts to $69.82 million.
Technical Picture
Here’s a quick look at Insulet Corporation’s (PODD) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 24.22%, suggesting the stock is oversold, with a 40.01% historical volatility rate.
The stochastic %K and %D were 7.96% and 4.36% respectively, while the average true range (ATR) was 8.76. Based on the 14-day stochastic reading of 17.87%, the RSI (14) reading is 21.94%. On the 9-day MACD Oscillator, the stock is at -8.51, and the 14-day reading is at -19.02.
Analyst Ratings
In its most recent analyst report, Citigroup raised its rating on Insulet Corporation (NASDAQ: PODD) to a Buy. Prior to this, analysts firm rated the stock as a Neutral. Analysts have assigned Insulet Corporation (PODD) an Overweight rating. PODD is a stock that is recommended for selling by 0 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 1 analyst. Among the analysts who rate the stock, 1 rate it overweight and 11 others recommend it as a buy.
What is PODD’s price target for the next 12 months?
The current consensus forecast for the stock is between $208.00 and $360.00, with a median target price of $299.00. In analyzing these forecasts, the average price target given by analysts for Insulet Corporation (PODD) is $291.53.
